ChemicalBook > CAS DataBase List > MCC950

MCC950

Product Name
MCC950
CAS No.
210826-40-7
Chemical Name
MCC950
Synonyms
CP-456773;CRID3;CRID 3;MCC950;CRID-3;CS-2292;CAS:210826-40-7;MCC950 (MCC-950;MCC950, 10 mM in DMSO;MCC950 (Synonyms: CP-456773
CBNumber
CB52744215
Molecular Formula
C20H24N2O5S
Formula Weight
404.48
MOL File
210826-40-7.mol
More
Less

MCC950 Property

Melting point:
239 °C
Density 
1.396±0.06 g/cm3(Predicted)
storage temp. 
-20°C
solubility 
Soluble in DMSO (up to 40 mg/ml) or in Water (up to 30 mg/ml)
pka
4.74±0.10(Predicted)
form 
solid
color 
White
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO or distilled water may be stored at -20°C for up to 1 month.
InChI
InChI=1S/C20H24N2O5S/c1-20(2,24)14-10-17(27-11-14)28(25,26)22-19(23)21-18-15-7-3-5-12(15)9-13-6-4-8-16(13)18/h9-11,24H,3-8H2,1-2H3,(H2,21,22,23)
InChIKey
HUUSXLKCTQDPGL-UHFFFAOYSA-N
SMILES
O1C=C(C(O)(C)C)C=C1S(NC(NC1=C2C(=CC3CCCC1=3)CCC2)=O)(=O)=O
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H303May be harmfulif swallowed

H320Causes eye irritation

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P312Call a POISON CENTER or doctor/physician if you feel unwell.

P337+P313IF eye irritation persists: Get medical advice/attention.

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
17510
Product name
MCC950
Purity
≥98%
Packaging
1mg
Price
$81
Updated
2024/03/01
Cayman Chemical
Product number
17510
Product name
MCC950
Purity
≥98%
Packaging
5mg
Price
$336
Updated
2024/03/01
Cayman Chemical
Product number
17510
Product name
MCC950
Purity
≥98%
Packaging
10mg
Price
$593
Updated
2024/03/01
Cayman Chemical
Product number
17510
Product name
MCC950
Purity
≥98%
Packaging
25mg
Price
$1184
Updated
2024/03/01
TRC
Product number
M199775
Product name
MCC-950
Packaging
10mg
Price
$425
Updated
2021/12/16
More
Less

MCC950 Chemical Properties,Usage,Production

Description

MCC-950 (210826-40-7) was originally found to act as a cytokine release inhibitory drug (CRID), arresting activated monocytes and preventing activation of caspase-1.1?Discovered to be a novel inhibitor of the NLRP3 and AIM2 inflammasomes.2?MCC-950 blocks canonical and noncanonical NLRP3 activation at nanomolar concentrations.3?Inhibits interleukin 1β (IL-1β) secretion?in vivo?and attenuates the severity of experimental autoimmune encephalomyelitis (an MS disease model).3?Disrupts the interaction between AIM2 and ASC in a reconstituted cell-free inflammasome.4?MCC-950 is a valuable new tool for exploring the pathophysiology of NLRP3.

Uses

MCC950 selectively inhibits pyrin domain-containing protein 3 (NLRP3) inflammasome, a protein complex involved in the inflammatory process (1). The NLRP3 inflammasome is related to a wide range of immune disorders such as multiple sclerosis, inflammatory bowel disease, auto-immune and auto-inflammatory diseases (2). MCC950 has been shown to specifically inhibit the activation of NLRP3 but not the AIM2, NLRC4 or NLRP1 inflammasomes (1). MCC950 is a potential therapeutic for NLRP3-associated syndromes.

in vivo

MCC950 reduces Interleukin-1p (IL-1β) production and attenuates the severity of experimental autoimmune encephalomyelitis (EAE), a disease model of multiple sclerosis. Pre-treatment with MCC950 reduces serum concentrations of IL-1β and IL-6 while it does not considerably decrease the amount of TNF-α. Treatment of mice with MCC950 delays the onset and reduced the severity of EAE. Intracellular cytokine staining and FACS analysis of brain mononuclear cells from mice sacrificed on day 22 shows modestly reduced frequencies of IL-17 and IFN-γ producing CD3+ T cells in MCC950 treated mice in comparison with PBS-treated mice. IFN-γ and particularly IL-17 producing cell numbers are also reduced in both the CD4+ and γδ+ sub-populations of CD3+ T cells[1].

IC 50

NLRP3

References

[1] RONALD E LALIBERTE. Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing.[J]. The Journal of Biological Chemistry, 2003, 278 19: 16567-16578. DOI:10.1074/jbc.m211596200
[2] REBECCA C COLL. The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes.[J]. PLoS ONE, 2011: e29539. DOI:10.1371/journal.pone.0029539
[3] REBECCA C COLL. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases[J]. Nature Medicine, 2015, 21 3: 248-255. DOI:10.1038/nm.3806
[4] NAOE KANEKO . Reconstituted AIM2 inflammasome in cell-free system[J]. Journal of immunological methods, 2015, 426: Pages 76-81. DOI:10.1016/j.jim.2015.08.004

MCC950 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

MCC950 Suppliers

Biokitchen
Tel
021-021-021-31663258 13795219287
Fax
021-31663258
Email
donghuanwen@126.com
Country
China
ProdList
8816
Advantage
58
Deyang Sino Biotech. Co., LTD
Tel
+86-19182167371 +86-19182167371;
Email
service@synlord.com
Country
China
ProdList
110
Advantage
58
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4757
Advantage
55
Shanghai jerryxing Biomedical Technology Co., Ltd
Tel
17721492509; 17721492509
Email
643638326@qq.com
Country
China
ProdList
4969
Advantage
58
Shanghai Boyle Chemical Co., Ltd.
Tel
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2922
Advantage
55
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
6003
Advantage
61
Beijing HwrkChemical Technology Co., Ltd
Tel
18515581800 18501085097
Fax
010-89508210
Email
sales.bj@hwrkchemical.com
Country
China
ProdList
9400
Advantage
55
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7552
Advantage
61
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
Country
China
ProdList
3506
Advantage
58
Finetech Industry Limited
Tel
027-87465837 19945049750
Fax
027-8777-2287
Email
sales@finetechnology-ind.com
Country
China
ProdList
9637
Advantage
58

210826-40-7, MCC950Related Search:


  • N-((1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl)-4-(2-hydroxypropan-2-yl)furan-2-sulfonamid
  • MCC950
  • CP-456773
  • N-[[(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)amino]carbonyl]-4-(1-hydroxy-1-methylethyl)-2-furansulfonamide
  • N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-4-(2-hydroxypropan-2-yl)furan-2-sulfonamide
  • CS-2292
  • MCC950 (MCC-950
  • 1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[4-(2-hydroxypropan-2-yl)furan-2-yl]sulfonylurea
  • 2-Furansulfonamide, N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]-4-(1-hydroxy-1-methylethyl)-
  • N-[[(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)amino]carbonyl]-4-(1-hydroxy-1-methylethyl)-2-furansulfonamChemicalbookide
  • CRID 3
  • CRID3
  • CRID-3
  • MCC950, 10 mM in DMSO
  • CAS:210826-40-7
  • MCC950 (Synonyms: CP-456773
  • 210826-40-7
  • 21086-40-7